SEI Investments’s Juno Therapeutics, Inc. JUNO Stock Holding History

SEI Investments’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,428	Closed	-$111K	–	3832
2017 Q4	$111K	Buy	2,428 +1,137	+88%	+$56.7K	﹤0.01%	2106
2017 Q3	$58K	Buy	1,291 +1,240	+2,431%	+$42.3K	﹤0.01%	2238
2017 Q2	$2K	Buy	+51	New	+$1.26K	﹤0.01%	2901
2015 Q1	–	Sell	-85	Closed	-$4K	–	2434
2014 Q4	$4K	Buy	+85	New	+$3.8K	﹤0.01%	2009

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

SEI Investments's JUNO Position: Q1 2018 in Review

SEI Investments sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 2,428 shares — an estimated $111K sold.

SEI Investments first reported a position in JUNO in Q4 2014 and held it in 4 quarters. The position peaked at $111K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

SEI Investments reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
SEI Investments sold 2,428 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $111K.
SEI Investments first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 4 quarters.
SEI Investments's Juno Therapeutics, Inc. position peaked at $111K in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on SEI Investments's 13F filing for Q1 2018, filed 11 May 2018.